199 related articles for article (PubMed ID: 18382265)
1. Clopidogrel use in coronary heart disease and percutaneous coronary intervention.
Atiemo AD; Williams MS
J Investig Med; 2008 Apr; 56(4):689-700. PubMed ID: 18382265
[TBL] [Abstract][Full Text] [Related]
2. Clopidogrel in acute coronary heart disease.
Din JN; Fox KA
Am Heart Hosp J; 2005; 3(4):234-42. PubMed ID: 16330915
[TBL] [Abstract][Full Text] [Related]
3. Optimizing platelet P2Y12 inhibition for patients undergoing PCI.
Steinhubl S; Roe MT
Cardiovasc Drug Rev; 2007; 25(2):188-203. PubMed ID: 17614940
[TBL] [Abstract][Full Text] [Related]
4. The role of clopidogrel in the management of acute coronary syndromes.
Wodlinger AM; Pieper JA
Clin Ther; 2003 Aug; 25(8):2155-81. PubMed ID: 14512126
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.
Mitsios JV; Papathanasiou AI; Rodis FI; Elisaf M; Goudevenos JA; Tselepis AD
Circulation; 2004 Mar; 109(11):1335-8. PubMed ID: 15023882
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).
Wiviott SD; Antman EM; Gibson CM; Montalescot G; Riesmeyer J; Weerakkody G; Winters KJ; Warmke JW; McCabe CH; Braunwald E;
Am Heart J; 2006 Oct; 152(4):627-35. PubMed ID: 16996826
[TBL] [Abstract][Full Text] [Related]
7. High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy.
Leé S; Vargová K; Hizoh I; Horváth Z; Gulácsi-Bárdos P; Sztupinszki Z; Apró A; Kovács A; Préda I; Tóth-Zsámboki E; Kiss RG
Thromb Res; 2014 Feb; 133(2):257-64. PubMed ID: 24359966
[TBL] [Abstract][Full Text] [Related]
8. Controversies of oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention.
Rajagopal V; Bhatt DL
Semin Thromb Hemost; 2004 Dec; 30(6):649-55. PubMed ID: 15630671
[TBL] [Abstract][Full Text] [Related]
9. Clopidogrel and risk for acute coronary events.
Mood GR; Bhatt DL
Curr Atheroscler Rep; 2007 Nov; 9(5):401-8. PubMed ID: 18001624
[TBL] [Abstract][Full Text] [Related]
10. Current Evidence on Platelet P2Y12 Receptor Inhibitors: Is There Still a Role for Clopidogrel in 2015?
Qutub MA; Chong AY; So DY
Can J Cardiol; 2015 Dec; 31(12):1481-4. PubMed ID: 26243350
[TBL] [Abstract][Full Text] [Related]
11. The thienopyridines in coronary artery disease.
Berger PB
Curr Cardiol Rep; 1999 Sep; 1(3):192-8. PubMed ID: 10980841
[TBL] [Abstract][Full Text] [Related]
12. Optimal antiplatelet treatment for percutaneous coronary intervention: clopidogrel vs. ticlopidine.
Almsherqi ZA; McLachlan CS; Mossop P; Deng Y
Int J Cardiol; 2007 Jan; 114(1):101-2. PubMed ID: 16343664
[TBL] [Abstract][Full Text] [Related]
13. Emerging antiplatelet therapies in percutaneous coronary intervention: a focus on prasugrel.
Martin MT; Spinler SA; Nutescu EA
Clin Ther; 2011 Apr; 33(4):425-42. PubMed ID: 21635989
[TBL] [Abstract][Full Text] [Related]
14. Prasugrel: a critical comparison with clopidogrel.
Reinhart KM; White CM; Baker WL
Pharmacotherapy; 2009 Dec; 29(12):1441-51. PubMed ID: 19947804
[TBL] [Abstract][Full Text] [Related]
15. Clopidogrel use in coronary artery disease.
Baggish AL; Sabatine MS
Expert Rev Cardiovasc Ther; 2006 Jan; 4(1):7-15. PubMed ID: 16375623
[TBL] [Abstract][Full Text] [Related]
16. The role of clopidogrel in revascularized and nonrevascularized patients with acute coronary syndromes.
Collins JS; Gurm HS
Am J Cardiovasc Drugs; 2007; 7(3):159-68. PubMed ID: 17610343
[TBL] [Abstract][Full Text] [Related]
17. Prasugrel versus clopidogrel antiplatelet therapy after acute coronary syndrome: matching treatments with patients.
Tcheng JE; Mackay SM
Am J Cardiovasc Drugs; 2012 Apr; 12(2):83-91. PubMed ID: 22316323
[TBL] [Abstract][Full Text] [Related]
18. The state of periprocedural antiplatelet therapy after recent trials.
Desai NR; Bhatt DL
JACC Cardiovasc Interv; 2010 Jun; 3(6):571-83. PubMed ID: 20630450
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of enhanced inhibition of P2Y12-mediated platelet aggregation in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Capranzano P; Mehran R; Tamburino C; Stone GW; Dangas G
Hosp Pract (1995); 2010 Nov; 38(4):38-43. PubMed ID: 21068525
[TBL] [Abstract][Full Text] [Related]
20. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
Reaume KT; Regal RE; Dorsch MP
Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
